Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;34(2):348-355.
doi: 10.1111/jce.15763. Epub 2022 Dec 21.

Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry

Zayd A Eldadah  1 , Amin Al-Ahmad  2 , T Jared Bunch  3 , David B Delurgio  4 , Rahul N Doshi  5 , Bruce G Hook  6 , Patrick M Hranitzky  7 , Charles A Joyner  8 , Suneet Mittal  9 , Christopher Porterfield  10 , Javier E Sanchez  7 , Senthil K Thambidorai  11 , Oussama M Wazni  12 , H Thomas McElderry  13
Affiliations

Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry

Zayd A Eldadah et al. J Cardiovasc Electrophysiol. 2023 Feb.

Abstract

Introduction: Early and safe ambulation can facilitate same-day discharge (SDD) following catheter ablation, which can reduce resource utilization and healthcare costs and improve patient satisfaction. This study evaluated procedure success and safety of the VASCADE MVP venous vascular closure system in patients with atrial fibrillation (AF).

Methods: The AMBULATE SDD Registry is a two-stage series of postmarket studies in patients with paroxysmal or persistent AF undergoing catheter ablation followed by femoral venous access-site closure with VASCADE MVP. Efficacy endpoints included SDD success, defined as the proportion of patients discharged the same day who did not require next-day hospital intervention for procedure/access site-related complications, and access site sustained success within 15 days of the procedure.

Results: Overall, 354 patients were included in the pooled study population, 151 (42.7%) treated for paroxysmal AF and 203 (57.3%) for persistent AF. SDD was achieved in 323 patients (91.2%) and, of these, 320 (99.1%) did not require subsequent hospital intervention based on all study performance outcomes. Nearly all patients (350 of 354; 98.9%) achieved total study success, with no subsequent hospital intervention required. No major access-site complications were recorded. Patients who had SDD were more likely to report procedure satisfaction than patients who stayed overnight.

Conclusion: In this study, 99.7% of patients achieving SDD required no additional hospital intervention for access site-related complications during follow-up. SDD appears feasible and safe for eligible patients after catheter ablation for paroxysmal or persistent AF in which the VASCADE MVP is used for venous access-site closure.

Keywords: VASCADE MVP; atrial fibrillation; catheter ablation; patient-reported outcomes; same-day discharge.

PubMed Disclaimer

References

REFERENCES

    1. Hosseini SM, Rozen G, Saleh A, et al. Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013. JACC Clin Electrophysiol. 2017;3:1240-1248.
    1. Kowalski M, Parikh V, Salcido JR, et al. Same-day discharge after cryoballoon ablation of atrial fibrillation: a multicenter experience. J Cardiovasc Electrophysiol. 2021;32:183-190.
    1. He H, Datla S, Weight N, et al. Safety and cost-effectiveness of same-day complex left atrial ablation. Int J Cardiol. 2021;322:170-174.
    1. König S, Svetlosak M, Grabowski M, et al. Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey. Europace. 2021;23:149-156.
    1. Deyell MW, Leather RA, Macle L, et al. Efficacy and safety of same-day discharge for atrial fibrillation ablation. JACC Clin Electrophysiol. 2020;6:609-619.

Publication types

LinkOut - more resources